Page 194 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 194

CHAPTER 10  Surgical Oncology  173


            60.   Cornell  K, Waters  DJ: Impaired wound healing in the cancer    81.   Barry KS, Case JB, Winter MD, et al.: Diagnostic usefulness of
               patient: effects of cytotoxic therapy and pharmacologic modulation   laparoscopy versus exploratory laparotomy for dogs with suspected
               by growth factors, Vet Clin North Am Small Anim Pract 25:111–  gastrointestinal obstruction,  J Am  Vet Med Assoc 251:307–314,
  VetBooks.ir   61.   McEntee MC: Principles of adjunct radiotherapy and chemother-   82.   Holak P, Adamiak Z, Jałyński M, et al.: Laparoscopy-guided pros-
                                                                     2017.
               131, 1995.
               apy, Vet Clin North Am Small Anim Pract 25:133–148, 1995.
                                                                     2010.
            62.   Ferguson MK: The effect of antineoplastic agents on wound heal-  tate biopsy in dogs–a study of 13 cases, Pol J Vet Sci 13:765–766,
               ing, Surg Gyn Obstet 154:421–429, 1982.            83.   Shaver SL, Mayhew PD, Steffey MA, et al.: Short-term outcome
            63.   Graves G, Cunningham P, Raaf JH: Effect of chemotherapy on the   of multiple port laparoscopic splenectomy in 10 dogs,  Vet Surg
               healing of surgical wounds, Clin Bull 10:144–149, 1980.  44(Suppl 1):71–75, 2015.
            64.   Laing EJ: The effects of antineoplastic agents on wound healing:    84.   Wright  T, Singh A, Mayhew PD, et  al.: Laparoscopic-assisted
               guidelines for combined use of surgery and chemotherapy, Com-  splenectomy in dogs: 18 cases (2012-2014), J Am Vet Med Assoc
               pend Contin Educ Pract Vet 11:136–143, 1989.          248:916–922, 2016.
            65.   Dernell WS, Withrow SJ, Straw RC, et al.: Intracavitary treatment    85.   Mayhew PD, Sutton JS, Singh A, et al.: Complications and short-
               of soft tissue sarcomas in dogs using cisplatin in a biodegradable   term outcomes associated with single-port laparoscopic splenec-
               polymer, Anticancer Res 17:4499–4506, 1997.           tomy in dogs, Vet Surg 47:O67–O74, 2018.
            66.   Fisher B, Gunduz N, Saffer EA: Influence of the interval between    86.   Jiménez  Peláez  M,  Bouvy  BM,  Dupré  GP:  Laparoscopic  adre-
               primary tumor removal and chemotherapy on kinetics and growth   nalectomy for treatment of unilateral adrenocortical carcinomas:
               of metastases, Cancer Res 43:1488–1492, 1983.         technique, complications, and results in seven dogs,  Vet Surg
            67.   Fisher B: Cancer surgery: a commentary, Cancer Treat Rep 68:31–  37:444–453, 2008.
               41, 1984.                                          87.   Pitt KA, Mayhew PD, Steffey MA, et al.: Laparoscopic adrenalec-
            68.   Bray J, Polton G: Neoadjuvant and adjuvant chemotherapy com-  tomy for removal of unilateral noninvasive pheochromocytomas in
               bined  with anatomical  resection  of feline  injection-site  sarcoma:   10 dogs, Vet Surg 45:O70–O76, 2016.
               results in 21 cats, Vet Comp Oncol 14:147–160, 2016.   88.   MacEwen EG, Hayes AA, Harvey HJ, et al.: Prognostic factors for
            69.   Tepper J, Million RR: Radiation therapy and surgery, Am J Clin   feline mammary tumors, J Am Vet Med Assoc 185:201–204, 1984.
               Oncol 11:381–385, 1988.                            89.   Golinger RC: Breast cancer controversies: surgical decisions, Semin
            70.   Sequin B, McDonald DE, Kent MS, et al.: Tolerance of cutaneous   Oncol 7:444–459, 1980.
               or mucosal flaps placed into a radiation therapy field of dogs, Vet    90.   Gemignani F, Mayhew PD, Giuffrida MA, et al.: Association of
               Surg 34:214–222, 2005.                                surgical approach with complication rate, progression-free sur-
            71.   MacEwen EG, Withrow SJ, Patnaik AK: Nasal tumors in the dog:   vival time, and disease-specific survival time in cats with mam-
               retrospective evaluation of diagnosis, prognosis, and treatment,    mary adenocarcinoma: 107 cases (1991-2014), J Am Vet Med Assoc
               J Am Vet Med Assoc 170:45–48, 1977.                   252:1393–1402, 2018.
            72.   Adams WM, Bjorling DE, McAnulty JF, et al.: Outcome of accel-   91.   Bartels KE: Lasers in veterinary medicine: where have we been, and
               erated radiotherapy alone or accelerated radiotherapy followed by   where are we going? Vet Clin North Am Small Anim Pract 32:495–
               exenteration of the nasal cavity in dogs with intranasal neoplasia:   515, 2002.
               53 cases (1990–2002), J Am Vet Med Assoc 227:936–941, 2005.   92.   Gillams AR: Mini-review: the use of radiofrequency in cancer, Br J
            73.   Farese JP, Milner R, Thompson MS, et al.: Stereotactic radiosur-  Cancer 92:1825–1829, 2005.
               gery for the treatment of lower extremity osteosarcoma in dogs,      93.   Kennedy JE: High-intensity focused ultrasound in the treatment of
               J Am Vet Med Assoc 225:1567–1572, 2004.               solid tumours, Nature Rev 5:321–327, 2005.
            74.   Weisse C, Berent A, Todd K, et al.: Evaluation of palliative stenting    94.   Kodama M, Kodama T, Nishi Y, et al.: Does surgical stress cause
               for management of malignant urethral obstructions in dogs, J Am   tumor metastasis? Anticancer Res 12:1603–1616, 1992.
               Vet Med Assoc 229:226–234, 2006.                   95.   Blumberg N, Heal JM: Perioperative blood transfusion and solid
            75.   Berent AC, Weisse C, Beal MW, et al.: Use of indwelling, double-  tumor recurrence: a review, Cancer Invest 5:615–625, 1987.
               pigtail stents for treatment of malignant ureteral obstruction in    96.   Pollock RE, Lotzová E, Stanford SD: Surgical stress impairs natural
               dogs: 12 cases (2006–2009), J Am Vet Med Assoc 238:1017–1025,   killer cell programming of tumor for lysis in patients with sarcomas
               2011.                                                 and other solid tumors, Cancer 70:2192–2202, 1992.
            76.   Royals SR, Ellison GW, Adin CA: Use of an ultrasonically acti-   97.   Medleau L, Crowe DT, Dawe DL: Effect of surgery on the in vitro
               vated scalpel for splenectomy in 10 dogs with naturally occurring   response of canine peripheral blood lymphocytes to phytohemag-
               splenic disease, Vet Surg 34:174–178, 2005.           glutinin, Am J Vet Res 44:859–860, 1983.
            77.   Jackson J, Richter KP, Launer DP: Thoracoscopic partial pericardi-   98.   Murthy SM, Goldschmidt RA, Rao LN, et al.: The influence of
               ectomy in 13 dogs, J Vet Intern Med 13:529–533, 1999.  surgical trauma on experimental metastasis, Cancer 64:2035–2044,
            78.   Crumbaker  DM, Rooney MB, Case JB: Thoracoscopic subtotal   1989.
               pericardiectomy and right atrial mass resection in a dog, J Am Vet    99.   Navarro M, Lozano R, Román A, et al.: Anesthesia and immuno-
               Med Assoc 237:551–554, 2010.                          suppression in an experimental model, Eur Surg Res 22:317–322,
            79.   Wormser C, Singhal S, Holt DE, et al.: Thoracoscopic-assisted pul-  1990.
               monary surgery for partial and complete lung lobectomy in dogs     100.   Meakins JL: Surgeons, surgery, and immunomodulation, Arch Surg
               and cats: 11 cases (2008-2013), J Am Vet Med Assoc 245:1036–  126:494–498, 1991.
               1041, 2014.                                         101.   Cady B: Basic principles in surgical oncology, Arch Surg 132:338–
            80.   Bleakley S, Duncan CG, Monnet E: Thoracoscopic lung lobectomy   346, 1997.
               for primary lung tumors in 13 dogs, Vet Surg 44:1029–1035, 2015.
   189   190   191   192   193   194   195   196   197   198   199